BioSpace News Archive

Braeburn’s application for final approval of BRIXADI is remanded back to FDA for reconsideration “with deliberate speed.”

New clinical findings reported in multiple peer-reviewed studies

The leader in drug discount management software adds a variety of talent to advance mission of adding transparency to the business of health care.

Governments across the world are taking initiatives to increase awareness and provide funding for the development of new drugs for the treatment of sexually transmitted diseases.

This review proposes a new approach to treating autoimmune and inflammatory diseases based on lessons from new generation influenza vaccines.

Luna Design and Innovation Inc., a Toronto-based biotechnology company, announced that it has been selected as an Official Channel Partner for Blue Origin’s New Shepard reusable suborbital rocket system.

111, Inc., a leading integrated online and offline healthcare platform, announced that its online retail pharmacy “1 Drugstore” has won two prestigious industry awards.

BlueWillow Biologics® today announced the issuance of U.S. patent number 10,206,996 to BlueWillow for the development of an intranasal NanoVax® herpes simplex virus (HSV) vaccine.

Digi International®, (NASDAQ: DGII), (www.digi.com), a leading global provider of Internet of Things (IoT) connectivity products and services, is pleased to announce that its Digi® WR54, an extremely reliable, secure, high-performance wireless router for complex mobile and industrial environments, is now tested and approved for use on the FirstNet communications platform.

Nurx, the health tech company addressing sensitive health needs and the leading online provider for birth control, is now available in Kentucky